TFA
TXG icon

Toth Financial Advisory’s 10x Genomics TXG Stock Holding History

Toth Financial Advisory’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15
Closed -$1K – 774
2022
Q1 		$1K Hold
15
– – ﹤0.01% 688
2021
Q4 		$2K Hold
15
– – ﹤0.01% 667
2021
Q3 		$2K Hold
15
– – ﹤0.01% 677
2021
Q2 		$3K Hold
15
– – ﹤0.01% 567
2021
Q1 		$3K Buy
+15
New +$2.59K ﹤0.01% 563

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Toth Financial Advisory's TXG Position: Q2 2022 in Review

Toth Financial Advisory sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 15 shares — an estimated $1K sold.

Toth Financial Advisory first reported a position in TXG in Q1 2021 and held it in 5 quarters. The position peaked at $3K in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

  • Toth Financial Advisory reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
  • Toth Financial Advisory sold 15 10x Genomics shares in Q2 2022, an estimated $1K.
  • Toth Financial Advisory first reported a position in 10x Genomics in Q1 2021 and held it in 5 quarters.
  • Toth Financial Advisory's 10x Genomics position peaked at $3K in Q2 2021.
  • 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Toth Financial Advisory's 13F filing for Q2 2022, filed 25 Jul 2022.